. Author manuscript; available in PMC: 2023 Aug 1.

Published in final edited form as: J Neural Transm (Vienna). 2022 Jun 26;129(8):1001–1009. doi: 10.1007/s00702-022-02523-3

Table 4:

Relationship between MGN [¹⁸F]FEOBV binding in the medial geniculate nucleus (MGN) and the presence of imbalance, falls and FoG in persons with PD (n=54).

VAChT region	PIGD status subgroup model	Age	Duration	Gender	Striatal dopamine [¹¹C]DTBZ PET	Total model
MGN	Imbalance status F=5.20, P=0.027 (9.6%^* lower in HY ≥2.5 stage stage)	F=3.9, P=0.054	F=0.01, P=0.91	F=2.2, P=0.14	F=3.2, P=0.08	R²=0.28, F=3.6, P=0.008
MGN	Fall status F=5.9, P=0.019 (9.9%^* lower in fallers)	F=6.2, P=0.017	F=0.2, P=0.69	F=0.8, P=0.39	F=1.8, P=0.18	R²=0.29, F=3.8, P=0.006
MGN	FoG status F=13.5, P=0.0006 (22%^* lower in freezers)	F=3.6, P=0.07	F=0.7, P=0.41	F=0.8, P=0.37	F=0.04, P=0.84	R²=0.38, F=5.7, P=0.0004

ANCOVA F-values (with levels of significance) are listed for the group effects and age, duration of disease, gender, striatal dopamine [¹¹C]DTBZ PET binding and total model effects. FoG = freezing of gait.

covariate adjusted